D-1321-2019 Class I Terminated

Recalled by Stiff Boy LLC — Englewood, NJ

FDA drug recall D-1321-2019 was initiated by Stiff Boy LLC on May 6, 2019 and is designated Class I. Reason for recall: Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis. The recall status is terminated (terminated Sep 16, 2025). Affected quantity: 1000 boxes.

Recall details

Product Type
Drugs
Report Date
Jun 5, 2019
Initiation Date
May 6, 2019
Termination Date
Sep 16, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1000 boxes

Product description

The Beast, The Beast can be taken under the situation of Heart disease and even after drinking, 4600 mg X 4 Capsules per packet.

Reason for recall

Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis.

Distribution pattern

Nationwide

Code information

All lots

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1321-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1321-2019. Report a data issue: hello@regdatalab.com.